<DOC>
	<DOCNO>NCT01369615</DOCNO>
	<brief_summary>The purpose study characterize long-term safety oxycodone hydrochloride ( HCl ) controlled-release ( CR ) tablets opioid experienced pediatric patient age 6 17 year , inclusive , moderate severe malignant and/or nonmalignant pain require opioid therapy complete 4 -week treatment period OTR3001 .</brief_summary>
	<brief_title>Long-Term Safety Twice Daily Oxycodone Hydrochloride Controlled-release Tablets Children Who Completed OTR3001</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Inclusion Criteria include : 1 . Male female patient age 6 17 year , inclusive , complete 4week study drug treatment study OTR3001 , base investigator 's judgment , benefit continue treatment oxycodone HCl CR 20 240 mg/day management moderate severe malignant nonmalignant pain ; 2 . Patients must tolerate oxycodone HCl CR therapy OTR3001 demonstrate start study ; 3 . Patients must willing able swallow oxycodone HCl CR tablet whole . Exclusion Criteria include : 1 . Patients ongoing adverse event OTR3001 , investigator 's opinion , disqualify participation study ; 2 . Female patient pregnant lactating ; 3 . Patients require opioid dos equivalent &lt; 20 mg/day &gt; 240 mg/day oxycodone treatment malignant nonmalignant pain ; 4 . Patients allergic oxycodone history allergy opioids ( criterion include patient experienced common opioid side effect [ eg , nausea , constipation ] ) ; 5 . Patients contraindicate use opioids ; 6 . Patients currently maintain methadone pain ; 7 . Patients abnormality vital sign , physical examination , laboratory test significant enough investigator deem patient appropriate study ; 8 . Patients plan surgery course study , exception placement central peripheral venous access device ; 9 . Patients currently take investigational medication/therapy study drug ( oxycodone HCl CR ) start screen study . Other protocol specific inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Malignant pain</keyword>
	<keyword>Nonmalignant pain</keyword>
	<keyword>Pain</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Opioid</keyword>
	<keyword>Moderate severe</keyword>
</DOC>